-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Wins Multiple Prestigious Awards in Hebei Province’s Pharmaceutical Industry
Category:
发布时间：2020-12-14
【概要描述】
On December 11, the fourth expanded meeting of the third session of the Hebei Provincial Pharmaceutical Industry Association was successfully held, co-hosted by the Hebei Provincial Pharmaceutical Industry Association and Shisi Pharmaceutical Group, the association’s current chair unit. Nearly 200 representatives from more than 100 pharmaceutical and related industrial enterprises across the province, along with journalists from news media, attended the meeting. During the event, outstanding enterprises that have made remarkable contributions to the development of the province’s pharmaceutical industry were commended. The meeting was chaired by Qu Jiguang, the 2020 chair of the Hebei Provincial Pharmaceutical Industry Association and Chairman of the Board of Shisi Pharmaceutical Group.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. was awarded the honorary title of “Top Ten Pharmaceutical Enterprises in Hebei Province for 2019” by the relevant association. Furthermore, Shijiazhuang No. 4 Pharmaceutical’s research projects—“Key Technology Development and Application of Moxifloxacin Hydrochloride Sodium Chloride Injection” and “Research and Industrialization of Balanced Saline Irrigation Solution”—as well as the research project of Hebei Guolong Pharmaceutical, a subsidiary of Shijiazhuang No. 4 Pharmaceutical Group—“Industrialization Development of a New Production Process for Hydroxyethyl Starch 130/0.4”—were each awarded the First Prize of the Hebei Provincial Pharmaceutical Science and Technology Award for the 2018–2019 period.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091